Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancer.

Saved in:
Bibliographic Details
Title: Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancer.
Authors: Chiang CL; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, Hong Kong, China. Electronic address: chiangcl@hku.hk., Chan KSK; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, Hong Kong, China., Li H; School of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Ng WT; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, Hong Kong, China., Chow JCH; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China., Choi HCW; School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Lam KO; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, Hong Kong, China., Lee VHF; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, Hong Kong, China., Ngan RKC; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, Hong Kong, China., Lee AWM; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, and University of Hong Kong-Shenzhen Hospital, Hong Kong, China., Eschrich SA; Cvergenx, Inc St Petersburg, FL, United States., Torres-Roca JF; Cvergenx, Inc St Petersburg, FL, United States., Wong JWH; School of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China. Electronic address: jwhwong@hku.hk.
Source: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Jul; Vol. 196, pp. 110287. Date of Electronic Publication: 2024 Apr 16.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0887
DOI:10.1016/j.radonc.2024.110287